Inventor

UHLMANN EUGEN

DE79 patents

⚠️ This page may combine multiple inventors who share the name “UHLMANN EUGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UHLMANN EUGEN

HOECHST AG

G cap-stabilized oligonucleotides

Stabilized oligonucleotides and their use

Phosphonomonoester nucleic acids, process for their preparation, and their use

Antisense oligonucleotides against HSV 1, and their preparation

PNA synthesis using an amino protecting group which is labile to weak acids

Enzymatic RNA molecules that cleave mutant N-RAS

Mini-proinsulin, its preparation and use

Phosphonomonoester nucleic acids process for their preparation and their use

Process for amplifying nucleic acids using DNA/PNA primers

Gene and gene structure coding for an aminotransferase, and microorganisms which express this gene

Oligonucleotide analogs, their preparation and use

Process for preparing substituted N-ethyglycine derivatives

Expression of a multigene RNA having self-splicing activity

Preparation of polypeptides having human γ-interferon activity

3&#39;-modified oligonucleotide derivatives

Gene and gene structure coding for an aminotransferase, and microorganisms which express this gene

PNA synthesis using a base-labile amino protecting group

Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids

3&#39;-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use

Process for 5&#39;-phosphorylation of nucleic acids

Methylphosphonic acid esters, processes for their preparation, and their use

Processes for the preparation of foreign proteins in streptomycetes

Preparation of secretin

AVENTIS PHARMA GMBH

G cap-stabilized oligonucleotides

3 modified oligonucleotide derivatives

Oligonucleotides for the inhibition of human eg5 expression

Polyamide nucleic acid derivatives, and agents and processes for preparing them

Modified antisense nucleotides complementary to a section of the human Ha-ras gene

TRANSLATE BIO MA INC

Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers

Multimetric oligonucleotide compounds

Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkers

Multimeric oligonucleotides compounds having cleavable linkers

UHLMANN EUGEN

Multimeric oligonucleotides compounds

Synthetic double-stranded oligonucleotides for specific inhibition of gene expression

C-class oligonucleotide analogs with enhanced immunostimulatory potency

Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity

COLEY PHARM GROUP INC

5′ CpG nucleic acids and methods of use

Nucleic acid-lipophilic conjugates

Semi-soft C-class immunostimulatory oligonucleotides

SANOFI AVENTIS DEUTSCHLAND

G cap-stabilized oligonucleotides

Oligoribonucleotide derivatives for specific inhibition of gene expression

GEN HOSPITAL CORP

Method of preparing fusion proteins

Fusion proteins, their preparation and use

KRIEG ARTHUR M

Immunostimulatory nucleic acids

Immunostimulatory nucleic acids

COLEY PHARM GMBH

Semi-soft c-class immunostimulatory oligonucleotides

CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity

DEBELAK HARALD

CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity

ADIUTIDE PHARMACEUTICALS GMBH

Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties

VOLLMER JORG

Combination motif immune stimulatory oligonucleotides with improved activity

3'-modified oligonucleotide derivatives

3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use

Process for 5'-phosphorylation of nucleic acids